Dhaka, Banglaesh || Sunday, 19 September 2021 || 4 Ashshin 1428
Headline: ■ Evaly top officials face travel ban ■ Government adamant about factory closure ■ Deadliest week in the Covid pandemic ■ Bangla Car is starting production ■ bKash suspends service with Evaly ■ Record 25 more die in RMCH Covid unit ■ 32 more deaths in Khulna Division ■ Schools to remain closed until July 31 ■ Bangladeshi killed again in BSF firing ■ Massive vaccination from July ■ Educational Institutions reopen after vaccination ■ Emergency use of Moderna vaccine approved
WTO panel mulls easing Covid vax protections
Deshsangbad Desk
Published : Wednesday, 9 June, 2021 at 2:30 PM, Update: 29.06.2021 11:59:10 PM

Envoys from the World Trade Organization (WTO) member nations are taking up a proposal to ease patents and other intellectual property protections for Covid-19 vaccines to help developing countries fight the pandemic, an idea backed by the Biden administration but opposed in other wealthy countries with strong pharmaceutical industries.

On the table for a two-day meeting of a WTO panel opening Tuesday is a revised proposal presented by India and South Africa for a temporary IP waiver on coronavirus vaccines. The idea has drawn support from more than 60 countries, which now include the United States and China, reported AP.

Some European Union member states oppose the idea, and the EU on Friday offered an alternative proposal that relies on existing World Trade Organization rules.

The 27-nation bloc said those rules currently allow governments to grant production licences - such as for Covid-19 vaccines or therapies - to manufacturers in their countries without the consent of the patent holders in times of emergency.

At stake in the meeting is whether the various sides can move toward drawing up a unified text, a key procedural step that could unlock accelerated negotiations. Inside observers cautioned, however, that a major breakthrough was not expected.

Even optimistic supporters acknowledge an IP waiver could take months to finalize because of solid resistance from some countries and WTO rules that require consensus on such decisions -- meaning a single country among the 164 members could scuttle any proposal. Even if adopted, ratification would also take time.

Advocacy groups, emboldened by the support the United States announced last month, have increasingly pushed the plan and insisted it would not be as difficult to carry out as detractors would say.

Doctors Without Borders, a Nobel Peace Prize-winning humanitarian agency, faulted the European Union, Switzerland, Norway and other holdouts on the IP waiver idea on Monday for employing alleged "delaying tactics."

Pharmaceutical companies insist that an IP waiver could dampen the incentive for researchers and entrepreneurs to innovate, and say vaccine-sharing by rich countries would be a much faster way to get shots to health workers and at-risk populations in the developing world.

The World Health Organization (WHO) has repeatedly inveighed against unequal access to vaccines, noting that rich countries scooped up supplies well in excess of the need of their own populations, while developing countries have obtained only a small fraction of the doses so far distributed and injected worldwide.


Latest News
Also >>
Most Read
We're in Facebook
Editor & Publisher
M. Hossain
Advisory Editor
Brig. Gen. Abdus Sabur Mia (Rtd.)

Tel : +88 02 48311101-2
Cell : +88 01713 601729, +88 01842 601729
Email : [email protected]
Developed & Maintenance by i2soft